Best medical device stocks
Updated November 16, 2026
We cover 183 US-listed medical device companies. The largest is UnitedHealth Group Inc. (UNH), worth $366.9B. These are the 20 with the highest analysis scores today.
| # | Company | Market cap | Upside to fair value | Dividend | Score |
|---|---|---|---|---|---|
| 1 | Resmed Inc.RMD | $33.7B | -28% | 1.1% | 4.2 |
| 2 | Globus Medical Inc.GMED | $9.3B | -22% | — | 3.6 |
| 3 | DexCom Inc.DXCM | $30.5B | -39% | — | 3.4 |
| 4 | Cigna GroupCI | $78.9B | +97% | 2.1% | 3.2 |
| 5 | UnitedHealth Group Inc.UNH | $366.9B | +2% | 2.3% | 3.0 |
| 6 | Boston Scientific Corp.BSX | $63.6B | -58% | — | 3.0 |
| 7 | Insulet Corp.PODD | $10.1B | -45% | — | 3.0 |
| 8 | Stryker Corp.SYK | $118.4B | -38% | 1.1% | 2.8 |
| 9 | Elevance Health, Inc.ELV | $96.0B | -2% | 1.6% | 2.8 |
| 10 | Ufp Technologies Inc.UFPT | $2.4B | -57% | — | 2.8 |
| 11 | Agilent Technologies, Inc.A | $48.9B | -42% | 0.6% | 2.6 |
| 12 | West Pharmaceutical Services Inc.WST | $29.1B | -71% | 0.2% | 2.6 |
| 13 | Oscar Health, Inc.OSCR | $9.6B | +73% | — | 2.6 |
| 14 | Humana Inc.HUM | $55.0B | +12% | 0.8% | 2.4 |
| 15 | Envista Holdings CorpNVST | $3.9B | -24% | — | 2.4 |
| 16 | Penumbra IncPEN | $12.6B | -76% | — | 2.2 |
| 17 | Bio-rad Laboratories, Inc.BIO | $9.7B | -61% | — | 2.2 |
| 18 | Clover Health Investments, Corp. /deCLOV | $2.6B | -70% | — | 2.2 |
| 19 | Becton Dickinson & Co.BDX | $59.1B | -41% | 1.9% | 2.0 |
| 20 | Labcorp Holdings Inc.LH | $30.1B | -14% | 0.8% | 2.0 |
A closer look at the top three
Resmed Inc. (RMD): It has revenue growth of 10% a year over three years, an average net margin of 25%, a P/E of about 22, an intrinsic value about 28% below the current price and an overall score of 4.2 out of 5 (strong company).
Globus Medical Inc. (GMED): It has revenue growth of 42% a year over three years, an average net margin of 10%, a P/E of about 17, an intrinsic value about 22% below the current price and an overall score of 3.6 out of 5 (good, with some weak spots).
DexCom Inc. (DXCM): It has revenue growth of 17% a year over three years, an average net margin of 16%, a P/E of about 32, an intrinsic value about 39% below the current price and an overall score of 3.4 out of 5 (good, with some weak spots).
Frequently asked questions
What is the best medical device stock right now?
By today’s analysis score, Resmed Inc. (RMD) ranks first with 4.2 out of 5. A score is one measure and does not replace a full analysis.
How many medical device stocks are listed in the US?
Our data covers 183 medical device companies, each with its own analysis page.
How is the 0–5 score calculated?
Each stock faces five numeric tests in each of five areas (value, future, past, financial health and shareholder returns); the overall score is the average of the five.
More lists and tools
Lists are generated automatically from SEC filings and market prices and rebuilt every day. They are a starting point for research, not a recommendation to buy or sell.